1. Home
  2. NKTX vs FEIM Comparison

NKTX vs FEIM Comparison

Compare NKTX & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • FEIM
  • Stock Information
  • Founded
  • NKTX 2015
  • FEIM 1961
  • Country
  • NKTX United States
  • FEIM United States
  • Employees
  • NKTX N/A
  • FEIM N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • NKTX Health Care
  • FEIM Industrials
  • Exchange
  • NKTX Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • NKTX 170.8M
  • FEIM 173.6M
  • IPO Year
  • NKTX 2020
  • FEIM N/A
  • Fundamental
  • Price
  • NKTX $2.05
  • FEIM $15.92
  • Analyst Decision
  • NKTX Strong Buy
  • FEIM
  • Analyst Count
  • NKTX 5
  • FEIM 0
  • Target Price
  • NKTX $15.20
  • FEIM N/A
  • AVG Volume (30 Days)
  • NKTX 853.6K
  • FEIM 39.8K
  • Earning Date
  • NKTX 03-20-2025
  • FEIM 03-13-2025
  • Dividend Yield
  • NKTX N/A
  • FEIM 6.28%
  • EPS Growth
  • NKTX N/A
  • FEIM 183.83
  • EPS
  • NKTX N/A
  • FEIM 0.82
  • Revenue
  • NKTX N/A
  • FEIM $60,188,000.00
  • Revenue This Year
  • NKTX N/A
  • FEIM N/A
  • Revenue Next Year
  • NKTX N/A
  • FEIM N/A
  • P/E Ratio
  • NKTX N/A
  • FEIM $19.39
  • Revenue Growth
  • NKTX N/A
  • FEIM 21.33
  • 52 Week Low
  • NKTX $1.96
  • FEIM $8.62
  • 52 Week High
  • NKTX $16.24
  • FEIM $20.33
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 39.74
  • FEIM 36.36
  • Support Level
  • NKTX $1.96
  • FEIM $15.61
  • Resistance Level
  • NKTX $2.35
  • FEIM $17.52
  • Average True Range (ATR)
  • NKTX 0.15
  • FEIM 0.75
  • MACD
  • NKTX -0.00
  • FEIM -0.13
  • Stochastic Oscillator
  • NKTX 19.15
  • FEIM 13.60

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: